Matinas BioPharma Holdings, Inc.
MTNB
$0.5571
-$0.0429-7.15%
AMEX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.61% | -10.85% | -13.25% | -9.26% | 11.64% |
| Total Depreciation and Amortization | 4.10% | 4.35% | 3.93% | 4.79% | 5.75% |
| Total Amortization of Deferred Charges | -67.92% | -83.17% | -104.64% | -91.94% | -77.52% |
| Total Other Non-Cash Items | -17.62% | -16.11% | -9.16% | -8.73% | -2.81% |
| Change in Net Operating Assets | -675.00% | 67.72% | 113.65% | 134.81% | 115.71% |
| Cash from Operations | -13.04% | -14.95% | 8.26% | 20.24% | 20.28% |
| Capital Expenditure | 100.00% | 96.76% | 37.18% | 75.56% | 70.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.12% | -79.73% | 136.75% | 133.32% | 79.14% |
| Cash from Investing | 13.95% | -79.16% | 149.02% | 171.52% | 105.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 54.55% | 69.23% | 77.78% | 65.00% | 46.34% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 83,500.00% | 71,176.92% | 377.78% | -108.86% | -111.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 181.53% | -742.53% | 65.65% | 85.61% | 65.31% |